An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M pro inhibitor
Authors:
- Daniel ZaidmanDZDaniel Zaidman
- Paul GehrtzPGPaul Gehrtz
- Mihajlo FilepMFMihajlo Filep
- Daren FearonDFDaren Fearon
- Jaime PriluskyJPJaime Prilusky
- Galit CohenGCGalit Cohen
- David OwenDODavid Owen
- Efrat ResnickEREfrat Resnick
- Claire Strain-DamerellCSClaire Strain-Damerell
- Petra LukacikPLPetra Lukacik
- Haim BarrHBHaim Barr
Preprint
Abstract
Designing covalent inhibitors is a task of increasing importance in drug discovery. Efficiently designing irreversible inhibitors, though, remains challenging. Here, we present covalentizer , a computational pipeline for creating irreversible inhibitors based on complex structures of targets with known reversible binders. For each ligand, we create a custom-made focused library of covalent analogs. We use covalent docking, to dock these tailored covalent libraries and to find those that can bind covalently to a nearby cysteine while keeping some of the main interactions of the original molecule. We found ~11,000 cysteines in close proximity to a ligand across 8,386 protein-ligand complexes in the PDB. Of these, the protocol identified 1,553 structures with covalent predictions. In prospective evaluation against a panel of kinases, five out of nine predicted covalent inhibitors showed IC 50 between 155 nM - 4.2 μM. Application of the protocol to an existing SARS-CoV-1 M pro reversible inhibitor led to a new acrylamide inhibitor series with low micromolar IC 50 against SARS-CoV-2 M pro . The docking prediction was validated by 11 co-crystal structures. This is a promising lead series for COVID-19 antivirals. Together these examples hint at the vast number of covalent inhibitors accessible through our protocol.Keywords
All Related Versions
- Published version: Cell Chemical Biology, 28 (12), 1795.
This publication has 72 references indexed in Scilit:
- Decision making inxia2Acta Crystallographica Section D Structural Biology, 2013
- Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL ProteaseJournal of Medicinal Chemistry, 2012
- Data processing and analysis with theautoPROCtoolboxActa Crystallographica Section D Structural Biology, 2011
- Assessing Synthetic Accessibility of Chemical Compounds Using Machine Learning MethodsJournal of Chemical Information and Modeling, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- Integration, scaling, space-group assignment and post-refinementActa Crystallographica Section D Structural Biology, 2010
- Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributionsJournal of Cheminformatics, 2009
- Route Designer: A Retrosynthetic Analysis Tool Utilizing Automated Retrosynthetic Rule GenerationJournal of Chemical Information and Modeling, 2009
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATPProceedings of the National Academy of Sciences of the United States of America, 2008
- RECAPRetrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial ChemistryJournal of Chemical Information and Computer Sciences, 1998